Summary
Introduction
Recently it was shown in rabbits and rats that stimulation of renal prostaglandin synthesis by arachidonic acid increases, whereas inhibition by indomethacin decreases, plasma renin activity (Larsson, Weber & Anggird, 1974; Weber, Holzgreve, Stephan & Herbst, 1975b) . The mechanisms by which the renal PG") system could modulate renin secretion from the kidney include indirect effects of the PGs on renal haemodynamics, adrenergic neurotransmission and renal control of sodium handling as well as direct effects on the reninproducing cells of the juxtaglonierular apparatus.
The present experiments are focused on two aspects of the interrelationship under discussion. First, on the direct effect of renal cortical PG on renin release and secondly on the elucidation of the components of the PG system that might be involved in the stimulation of renin release.
Methods

Studies in vivo
The materials and methods used in the experiments in rabbits and rats in vivo have been described in detail previously (Larsson et a/., 1974; Weber et a/., 1975b).
Studies in vitro
Materials. The natural PG precursor arachidonic acid (C20:4) was used as the sodium salt and was added to the incubation medium to final concentra-tions 04-50 pg/ml. A natural (PGG2; Hamberg, body weight) twice, 1 h and 10 min before taking out Svensson, Wakabayashi & Samuelsson, 1974) 100 rnl. After the pre-incubation period and during and added to the incubation medium to final the experimental periods aliquots were removed for concentrationsof 10-'2-10-6mol/l. ThePGsynthesis renin analysis in the incubation medium. Renin inhibitors indomethacin and 5,8,11 ,14-eicosatetrayrelease was determined by incubation with an excess noic acid were dissolved in ethanol/buffer ( I : 10).
of purified rabbit renin substrate and using a radioFor pretreatment by intravenous injection indoimmunoassay for angiotensin I as described previmethacin or ETA (5 mg/ml) was given (5 mg/kg ously (Weber, Held, Uhlich & Eigler, 1975a).
mol/l was used. 
Results
The results of the experiments in vivo and in vitro are summarized in Table 1 .
Infusion of sub-hypotensive doses of the PG precursor C20:4 into the aorta of rabbits and rats proximal to the origin of the renal arteries was followed by a significant increase of plasma renin activity. Treatment with indomethacin in a dose (5 mglkg body weight, intravenously) which inhibits 90% of renal PG production in rabbits decreased basal as well as stimulated plasma renin activities after total renal ischaemia for 20 min. Expansion of extracellular fluid volume (3 % body weight) by NaCl solution (154 mmolll) intravenously in rats did not change the C20:Cinduced increase of plasma renin activity.
Stimulation of PG biosynthesis by C20:4 in slices of rabbit kidney cortex significantly increased the release of renin, with a maximum of about 250% as compared with the control at 0.8-1.5 pg of C20:4/ml. Inhibition of PG synthesis by indomethacin or ETA decreased spontaneous as well as C20: 4stimulated renin release. A natural PG endoperoxide (PGGz, 0.8 pglml) and two stable synthetic PG endoperoxide analogues (EPA I, 2 bglrnl; EPA 11, 1.5 pglml) increased renin release almost to the same degree (about a%), whereas PGEz molll) had no effect on renin release and PGFz. molll) decreased it.
Discussion
The main finding of our studies in normal rabbits and rats is that stimulation of renal PG synthesis by infusion of the PG precursor arachidonic acid (C20:4) elicits a significant increase in plasma renin activity. On the other hand, inhibition of PG synthesis by indomethacin decreases plasma renin activity. Furthermore, from our experiments in rats it can be concluded that stimulation of the renal PG system by C20:4 increases renin release independently of salt-water balance, whereas the consequences of C20:4stimulated renal PG synthesis on kidney function are modulated by the extracellular volume (Weber et al., 1975b) . In addition, at least under some experimental conditions--such as total renal ischaemia (Weber et al., 1975a; Larsson & hggard, 1976b) , glycerol-induced acute renal failure (Torres, Strong, Romero & Wilson, 1975) and frusemide treatment (unpublished results; Rumpf, Frenzel, Lowitz & Scheler, 1975; Patak, Mookerje, Bentzel, Hysert, Babej & Lee, 1975) , renal PG synthesis might be an essential link in the reninrelease mechanism.
The question arises whether the increased renin release after administration of C20:4 in vivo is a direct effect of PG on the renin-producing cells in the kidney cortex or secondary to a variety of PGinduced changes of kidney function. The finding that changes of kidney function after volume expansion in rats does not alter C20:4stimulated renin release do suggest a direct action of renal PG on renin release but do not prove it (Weber et af.,  1975b) .
The recent demonstration of PG biosynthesis in the kidney cortex (Larsson & Xnggard, 1973 ,1976a provide a biochemical basis for a possible direct action of PGs onrenalcortical structures such as the juxtaglomerular apparatus, which regulates synthesis and release of renin in the epitheloid cells.
An important result of our studies in rabbit kidney slices is that incubation of renal cortex tissue with the PG precursor C20:4 induces a highly significant increase of renin release. That this effect is due to formation of PGs or PG endoperoxides is supported by the finding that indomethacin and ETA, two structurally different PG synthesis inhibitors, decreased basal as well as C20:4stimulated renin release. However, PGEt had no effect on renin release in our system in vitro, whereas PGF2. decreased renin release. This, together with the demonstration that a natural prostaglandin endoperoxide, PGGz, and two stable synthetic prostaglandin endoperoxide analogues, EPA I and EPA 11, increased renin release in oitro, raise the possibility that renin release is mediated directly by PG endoperoxides biosynthetized within renal cortical structures.
